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ABSTRACT 
Objective: The purpose of the present study was to reveal the potential pleotropic anti-inflammatory activity of two hmg-co Reductase inhibitors, 
Rosuvastatin and atorvastatin in comparison with standard drug diclofenac. 
Methods: The method used for screening anti-inflammatry activity was In vitro human red blood cell membrane stabilization method.  
Results: The results of our study revealed that atorvastatin and rosuvastatin showed effective in vitro(500mcg/ml) anti-inflammatory activity when 
compared with the standard drug diclofenac. 
Conclusion: The rosuvastatin was more potent anti-inflamatory drug when compared with atorvastatin.  
Keywords: Atorvastatin, Rosuvastatin, Membrane stabilizing, Anti-inflammatory. 
 
The process of inflammation includes activation of the number of 
enzymes, extravasation of inflammatory cells, release of mediators 
of inflammation, proliferation, tissue breakdown and repair [1]. It 
occurs in three different phases. The first phase of inflammation is 
characterized by an increase in vascular permeability resulted in 
fluid exudation from the blood into the interstitium. The 
infiltration of leucocytes, monocytes and macrophages from the 
blood into the inflamed tissues constitute the second phase of 
inflammation and the third one comprises of chronic proliferative 
phase leading to granuloma formation. The screening methods for 
the evaluation of potential anti-inflammatory agents are aimed to 
counteract these phases [2, 3]. At present the pharmaceutical 
research is concentrated to explore the potential pleotropic effects 
of clinically using safer drugs, as the discovery of a new agent with 
new therapeutic action is not only a time consuming complex 
procedure but also create greater financial burden to 
pharmaceutical companies. 
Statins are drugs which are in long term clinical use with adequate 
safety for the treatment of hyperlipidaemia, which act by inhibiting 
the enzyme HMG-Co reductase enzyme, a rate limiting enzyme 
involved in cholesterol biosynthesis [4]. Several clinical research 
trial reports suggest that the observed clinical benefit of statin 
therapy is much greater than that expected, which may be due to its 
potential anti-inflammatory activity. Inflammatory processes have 
an important role in the pathogenesis of the number of diseases like 
atherosclerosis and statins exhibit anti-inflammatory activity and 
reduce these events than expected [5, 6]. Numerous studies 
suggested that statins antagonize one of the major phagocytic cell, 
macrophage function, as the macrophages secreting matrix 
metalloproteinase capable of degrading the extracellular matrix and 
thus leads to atheromatous plaque to rupture [7, 8]. 
Our aim was to investigate whether statins exhibit any anti-
inflammatory activity independent of its cholesterol lowering effect; 
so that these agents may be useful in other disease conditions where 
inflammation is the root cause for disease amplifiation. Two statins 
atorvastatin(commonly used) and rosuvastatin (potent) were 
selected and HRBC membrane stabilization method was used for 
screening in vitro anti-inflammatory activity (Gandhisan etal. 1991) 
[9]. Since HRBC membrane is similar to lysosomal membrane, this 
method is an important in vitro screening method for anti-
inflammatory activity as the enzyme released from lysosomes have 
pivotal role in acute and chronic inflammation and also most of the 
currently available anti-inflammatory drugs act either by inhibiting 
these lysosomal enzymes or by stabilizing the lysosomal membrane 
[10, 11].  
Atorvastatin, rosuvastatin, and diclofenac reference samples were 
obtained from Ranbaxy pharmaceuticals, Pvt, Ltd, Punjab and are 
identified by taking IR spectra and which was comparable with 
reference standard spectra. The selected statins were dissolved in 
DiMethylSulphoxide(DMSO). 5mg of the drug was disolved in 10 
ml* of the solvent so as to get a final concentration of 500mcg/ml 
and standard drug diclofenac was dissolved in 10 ml* of distilled 
water to get a final concentration of 50mcg/ml. In order to 
conduct the anti-inflammatory activity, blood was collected from 
healthy human volunteer who had not taken any anti-
inflammatory drugs for two weeks prior to the experiment. The 
collected blood was mixed with equal volume of sterilized Alsever 
solution (2%dextrose, 0.8% sodium citrate, 0.5% citric acid and 
0.42% sodium chloride in water). The blood was centrifuged at 
3000 rpm and packed cells were washed with isosaline and a 10 
%(v/v) suspension was made with isosaline. Prepared the assay 
mixture by adding 1 ml* of drug solution (Diclofenac 50mcg/ml, 
statins 500mcg/ml), 1 ml of 0.15M phosphate buffer of pH 7.4, 2 
ml of hyposaline and 0.5 ml* of HRBC suspension. 1 ml* of distilled 
water was used in the control instead of drug solution. All the 
assay mixtures were incubated at 370
All the data are expressed as mean ± S. E. M. Statistical significance 
was determined by students ‘t’ test; P value less than 0.05 was 
regarded as significant. The in vitro anti-inflammatory activity of 
rosuvastatin(500mcg/ml) and atorvastatin(500mcg/ml) was found 
to be 62.8% and 47.4% respectively when compared with 74.8% of 
protection offered by standard drug diclofenac (50mcg/ml). Data 
shown in fig: 1. 
C for 30 min and centrifuged. 
The hemoglobin content in the supernatant solution was 
estimated using spectrophotometer at 560 nm. The percentage 
hemolysis was calculated by assuming the hemolysis produced in 
presence of distilled water as 100%[1, 3, 10, 11]. 
Percentage of haemolysis = [OD of test/ OD of control]100 
The percentage of HRBC membrane stabilization or protection was 
calculated by using the following formula;  
Percentage protection = [100-Percentage of haemolysis]. 
The control represent 100% lyses 
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Fig. 1: Graphical representation of antiinflammatry activity of statins 
 
Stabilization of human red blood cells membrane is a commonly 
used method for screening in vitro anti-inflammatory activity. RBC 
membrane is considered to be physiologicaly similar to lysosomal 
membrane, as both the membrenes are composed of same types of 
lipids and proteins. So it is assumed that stabilization of RBC 
membrane by an agent indirectly implies that the compound can 
stabilize the lysosomal membrane and exhibit anti-inflammatory 
activity; as many of the clinically available anti-inflammatory drugs 
act by stabilizing the lysosomal membrane. Stabilization of 
lysosomal membrane helps to prevent the release of inflammatory 
mediators such as bactericidal enzymes and proteases and thus 
limits the inflammatory process[14]. 
Non-steroidal anti-inflammatory drugs(NSAIDs) like diclofenac act 
by inhibiting the lysosomal enzymes cyclooxygenase, an enzyme 
which is responsible for conversion of membrane phospholipid, 
arachidonic acid into prostaglandins. Some of the NSAIDs are known 
to exhibit membrane stabilization due to osmotic loss of 
intracellular electrolyte and fluid components[15].  
The selected statins, atorvastatin and rosuvastatin at 500mcg/ml 
concentration exhibit significant membrane stabilization effects 
towards the hypotonicity induced lyses of erythrocyte membrane, 
which was comparable with standard drug diclofenac. Maximum in 
vitro anti-inflammatory activity was obtained with rosuvastatin 
(P<0.001) at 500mcg/ml concentration. Further in vivo studies using 
suitable animal models of inflammation will be needed to confirm 
the role of statins in inflammations. 
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